Fleebs-Logo
Details werden geladen...

Can Early Weight Loss Predict 1-Year GLP-1 Response?

Patient characteristics at baseline and weight loss in the first 3 months on a GLP-1 drug were tied to weight-loss outcomes at 1 year in patients using digital weight-management services.

Ähnliche Seiten

https://www.medscape.com/viewarticle/glp-1-gender-gap-why-are-men-being-left-out-2026a10013hm

GLP-1 Gender Gap: Why Are Men Being Left Out?

https://www.medscape.com/viewarticle/glp-1-gender-gap-why-are-men-being-left-out-2026a10013hm
https://www.medscape.com/p04/managing-glp-1-side-effects-and-endoscopy-risks-2026a10014gk

Managing GLP-1 Side Effects and Endoscopy Risks

https://www.medscape.com/p04/managing-glp-1-side-effects-and-endoscopy-risks-2026a10014gk
https://www.medscape.com/viewarticle/hair-loss-associated-glp-1-ras-appear-similar-race-2026a10014r5

Hair Loss Associated With GLP-1 RAs Appear Similar by Race

https://www.medscape.com/viewarticle/hair-loss-associated-glp-1-ras-appear-similar-race-2026a10014r5
https://www.medscape.com/viewarticle/after-glp-1-which-exit-strategy-keeps-weight-2026a10018gh

After a GLP-1: Which Exit Strategy Keeps the Weight Off?

https://www.medscape.com/viewarticle/after-glp-1-which-exit-strategy-keeps-weight-2026a10018gh
https://www.medscape.com/viewarticle/finding-link-between-olfactory-loss-and-obesity-q-2026a10013bt

Finding the Link Between Olfactory Loss and Obesity: A Q&A

https://www.medscape.com/viewarticle/finding-link-between-olfactory-loss-and-obesity-q-2026a10013bt
https://www.medscape.com/viewarticle/surpass-cvot-looks-beyond-heart-tirzepatide-signals-benefits-2026a10010mv

SURPASS-CVOT Looks Beyond the Heart: Tirzepatide Signals Benefits in Infection Mortality, Patient-Reported Outcomes

https://www.medscape.com/viewarticle/surpass-cvot-looks-beyond-heart-tirzepatide-signals-benefits-2026a10010mv